← Mechanisms of action
DDC
SINGLE PROTEINHomo sapiens
Preferred name: DOPA decarboxylase ChEMBL ↗
Linked proteins
Drugs acting on this target (9)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| benserazide | Inhibitor | experimental | Small molecule | DDC inhibitor |
| carbidopa (sinemet) | Inhibitor | approved | Small molecule | DDC inhibitor |
| foscarbidopa | Inhibitor | approved | Small molecule | DOPA decarboxylase inhibitor |
| fluorodopa (fluorodopa F18) | Substrate | approved | Small molecule | DDC substrate |
| aav-haadc-2 | Supplementation | experimental | Gene therapy | DDC supplementation |
| oxb-102 | Supplementation | experimental | Gene therapy | DDC supplementation |
| vgn-r09b | Supplementation | experimental | Gene therapy | supplementation - AADC |
| vy-aadc01 | Supplementation | experimental | Gene therapy | DDC supplementation |
| vy-aadc02 | Supplementation | experimental | Gene therapy | DDC supplementation |